MDGL (STOCKS)
Madrigal Pharmaceuticals, Inc. Common Stock
$481.000000
+2.170000 (+0.45%)
Prev close: $478.830000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- William J. Sibold
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10,939.46M
- Employees
- 528
- P/E (TTM)
- -36.98
- P/B (TTM)
- 17.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
16
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-4.96 | $-2.12 | -2.8368 | -133.61% |
|
Jun 2025 (Q2)
|
$-1.90 | $-3.71 | +1.8099 | +48.79% |
|
Mar 2025 (Q1)
|
$-3.32 | $-3.84 | +0.5163 | +13.46% |
|
Dec 2024 (Q4)
|
$-2.71 | $-4.33 | +1.6194 | +37.40% |
Financial Statements
| Revenues | $740.64M |
| Benefits Costs and Expenses | $1.03B |
| Costs And Expenses | $1.06B |
| Operating Expenses | $1.04B |
| Selling, General, and Administrative Expenses | $715.07M |
| Other Operating Expenses | $326.82M |
| Operating Income/Loss | -$307.48M |
| Income/Loss From Continuing Operations After Tax | -$289.13M |
| Income/Loss From Continuing Operations Before Tax | -$289.13M |
| Net Income/Loss | -$289.13M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$289.13M |
| Net Income/Loss Available To Common Stockholders, Basic | -$289.13M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$12.89 |
| Diluted Earnings Per Share | -$12.89 |
| Basic Average Shares | 67,001,251 |
| Diluted Average Shares | 67,001,251 |
| Assets | $1.36B |
| Current Assets | $1.35B |
| Cash | $1.11B |
| Inventory | $69.32M |
| Other Current Assets | $162.61M |
| Noncurrent Assets | $15.78M |
| Fixed Assets | $2.91M |
| Other Non-current Assets | $12.86M |
| Liabilities | $736.73M |
| Current Liabilities | $391.41M |
| Accounts Payable | $44.94M |
| Wages | $51.11M |
| Other Current Liabilities | $295.36M |
| Noncurrent Liabilities | $345.32M |
| Long-term Debt | $339.75M |
| Other Non-current Liabilities | $5.57M |
| Equity | $625.73M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $625.73M |
| Liabilities And Equity | $1.36B |
| Net Cash Flow From Operating Activities | -$160.58M |
| Net Cash Flow From Operating Activities, Continuing | -$160.58M |
| Net Cash Flow From Investing Activities | -$43.21M |
| Net Cash Flow From Investing Activities, Continuing | -$43.21M |
| Net Cash Flow From Financing Activities | $266.80M |
| Net Cash Flow From Financing Activities, Continuing | $266.80M |
| Net Cash Flow | $63.01M |
| Net Cash Flow, Continuing | $63.01M |
| Comprehensive Income/Loss | -$289.33M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$289.33M |
| Other Comprehensive Income/Loss | -$203.00K |